ALNY Insider Transactions — Page 6
1,886 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 501–600; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-28 | Sale | 59.0 | $244.11 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-28 | Sale | 121.0 | $243.23 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-28 | Sale | 300.0 | $242.44 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-28 | Sale | 127.0 | $241.51 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-28 | Sale | 78.0 | $240.32 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-28 | Sale | 35.0 | $239.18 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-28 | Sale | 34.0 | $238.33 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-28 | Sale | 42.0 | $236.51 |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2025-02-28 | Sale | 38.0 | $244.11 |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2025-02-28 | Sale | 78.0 | $243.23 |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2025-02-28 | Sale | 192.0 | $242.44 |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2025-02-28 | Sale | 82.0 | $241.51 |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2025-02-28 | Sale | 50.0 | $240.32 |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2025-02-28 | Sale | 23.0 | $239.18 |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2025-02-28 | Sale | 22.0 | $238.33 |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2025-02-28 | Sale | 28.0 | $236.51 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-28 | Sale | 69.0 | $244.11 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-28 | Sale | 142.0 | $243.23 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-28 | Sale | 352.0 | $242.44 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-28 | Sale | 149.0 | $241.51 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-28 | Sale | 91.0 | $240.32 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-28 | Sale | 41.0 | $239.18 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-28 | Sale | 40.0 | $238.33 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-28 | Sale | 51.0 | $236.51 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-28 | Sale | 37.0 | $244.11 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-28 | Sale | 75.0 | $243.23 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-28 | Sale | 187.0 | $242.44 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-28 | Sale | 79.0 | $241.51 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-28 | Sale | 48.0 | $240.32 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-28 | Sale | 22.0 | $239.18 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-28 | Sale | 21.0 | $238.33 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-28 | Sale | 27.0 | $236.51 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-18 | Sale | 83.0 | $259.1 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-18 | Sale | 76.0 | $257.79 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-18 | Sale | 80.0 | $256.05 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-18 | Sale | 115.0 | $251.6 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-18 | Sale | 1,086.0 | $250.21 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-18 | Sale | 80.0 | $259.1 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-18 | Sale | 107.0 | $257.99 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-18 | Sale | 83.0 | $256.05 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-18 | Sale | 110.0 | $251.6 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-18 | Sale | 306.0 | $250.73 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-18 | Sale | 862.0 | $250.11 |
| Greenstreet Yvonne | Chief Executive Officer | 2025-02-14 | Sale | 25.0 | $264.87 |
| Greenstreet Yvonne | Chief Executive Officer | 2025-02-14 | Sale | 21.0 | $263.33 |
| Greenstreet Yvonne | Chief Executive Officer | 2025-02-14 | Sale | 47.0 | $261.45 |
| Greenstreet Yvonne | Chief Executive Officer | 2025-02-14 | Sale | 38.0 | $260.57 |
| Greenstreet Yvonne | Chief Executive Officer | 2025-02-14 | Sale | 21.0 | $259.72 |
| Greenstreet Yvonne | Chief Executive Officer | 2025-02-14 | Sale | 59.0 | $258.07 |
| Greenstreet Yvonne | Chief Executive Officer | 2025-02-14 | Sale | 47.0 | $257.51 |
| Greenstreet Yvonne | Chief Executive Officer | 2025-02-14 | Sale | 98.0 | $256.29 |
| Greenstreet Yvonne | Chief Executive Officer | 2025-02-14 | Sale | 85.0 | $255.56 |
| Greenstreet Yvonne | Chief Executive Officer | 2025-02-14 | Sale | 201.0 | $254.35 |
| Greenstreet Yvonne | Chief Executive Officer | 2025-02-14 | Sale | 300.0 | $253.37 |
| Greenstreet Yvonne | Chief Executive Officer | 2025-02-14 | Sale | 271.0 | $252.5 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-14 | Sale | 20.0 | $264.87 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-14 | Sale | 17.0 | $263.33 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-14 | Sale | 37.0 | $261.45 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-14 | Sale | 30.0 | $260.57 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-14 | Sale | 17.0 | $259.72 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-14 | Sale | 47.0 | $258.07 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-14 | Sale | 37.0 | $257.51 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-14 | Sale | 78.0 | $256.29 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-14 | Sale | 68.0 | $255.56 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-14 | Sale | 160.0 | $254.35 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-14 | Sale | 239.0 | $253.37 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-14 | Sale | 217.0 | $252.5 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-14 | Sale | 14.0 | $264.87 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-14 | Sale | 12.0 | $263.33 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-14 | Sale | 26.0 | $261.45 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-14 | Sale | 21.0 | $260.57 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-14 | Sale | 12.0 | $259.72 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-14 | Sale | 33.0 | $258.07 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-14 | Sale | 26.0 | $257.51 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-14 | Sale | 53.0 | $256.29 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-14 | Sale | 47.0 | $255.56 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-14 | Sale | 110.0 | $254.35 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-14 | Sale | 164.0 | $253.37 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-14 | Sale | 145.0 | $252.5 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-14 | Sale | 32.0 | $264.87 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-14 | Sale | 27.0 | $263.33 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-14 | Sale | 60.0 | $261.45 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-14 | Sale | 49.0 | $260.57 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-14 | Sale | 27.0 | $259.72 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-14 | Sale | 77.0 | $258.07 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-14 | Sale | 60.0 | $257.51 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-14 | Sale | 126.0 | $256.29 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-14 | Sale | 110.0 | $255.56 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-14 | Sale | 258.0 | $254.35 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-14 | Sale | 386.0 | $253.37 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-14 | Sale | 349.0 | $252.5 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-01-27 | Sale | 52,592.0 | $285.0 |
| SHARP PHILLIP A | Director | 2025-01-23 | Sale | 11,250.0 | $275.0 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-12-12 | Sale | 1.0 | $255.8 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-12-12 | Sale | 140.0 | $254.37 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-12-12 | Sale | 100.0 | $252.94 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-12-12 | Sale | 778.0 | $251.68 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-12-12 | Sale | 426.0 | $250.08 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-12-12 | Sale | 186.0 | $248.99 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-12-12 | Sale | 121.0 | $247.48 |